Results 1 to 10 of about 17,578 (111)

Toward quantification of loop diuretic responsiveness for congestive heart failure [PDF]

Journal of Veterinary Internal Medicine, 2023
Diuretics, such as furosemide, are routinely administered to dogs with congestive heart failure (CHF). Traditionally, dose and determination of efficacy primarily are based on clinical signs rather than quantitative measures of drug action.
Mark A. Oyama, Darcy Adin
doaj   +2 more sources

Optimal Initial Intravenous Loop Diuretic Dosing in Acute Decompensated Heart Failure [PDF]

JACC: Advances
Background: Nearly one-half of patients admitted with acute decompensated heart failure (ADHF) are discharged with unresolved congestion, elevating rehospitalization risk.
Joshua A. Jacobs, PharmD, Spencer J. Carter, MD, Griffin Bullock, MD, Jessica R. Carey, PharmD, Irene Z. Pan, PharmD, M. Shea Kinsey, PharmD, MBA, MHSA, MS, Alexander R. Zheutlin, MD, MS, Chris J. Kapelios, MD, Shilpa Raju, MD, James C. Fang, MD, Kevin S. Shah, MD, Adam P. Bress, PharmD, MS   +11 more
doaj   +2 more sources

TRANSFORM-HF Trial: Choice of loop diuretic in acute heart failure does not matter! [PDF]

Journal of Family Medicine and Primary Care
The major clinical manifestations of heart failure (HF) are due to fluid retention and congestion, and thus, therapy targeting congestion plays a central role in HF management. Furosemide is by far the most commonly prescribed loop diuretic.
Akshyaya Pradhan, Arvind Jaiswal, Monika Bhandari   +2 more
doaj   +2 more sources

Impact of loop diuretic dosage in a population of patients with acute heart failure: a retrospective analysis [PDF]

Frontiers in Cardiovascular Medicine, 2023
BackgroundLoop diuretics are essential for managing congestion in acute heart failure (AHF) patients, but concerns exist about their dosing and administration. This study aims to explore the relationship between aggressive diuretic treatment and clinical
P. Meani, M. Pagnoni, G. M. Mondellini, S. Fiorenza, H. P. Brunner-La Rocca   +4 more
doaj   +2 more sources

Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension [PDF]

ESC Heart Failure
Aims The use of loop diuretics in pulmonary arterial hypertension (PAH) is less frequent compared with heart failure. The clinical and prognostic characteristics of PAH patients according to loop diuretic use remain unexplored.
Giulio Savonitto, Davide Barbisan, Pietro Ameri, Carlo Maria Lombardi, Simonetta Monti, Mauro Driussi, Piero Gentile, Luke Howard, Matteo Toma, Matteo Pagnesi, Valentino Collini, Carolina Bauleo, Marianna Adamo, Luciana D'Angelo, Chiara Nalli, Alberto Giannoni, Veronica Vecchiato, Emma Di Poi, Edoardo Airo, Marco Metra, Andrea Garascia, Gianfranco Sinagra, Francesco Lo Giudice, Davide Stolfo   +23 more
doaj   +2 more sources

Association between intestinal oedema and oral loop diuretic resistance in hospitalized patients with acute heart failure [PDF]

ESC Heart Failure, 2021
Aims Intestinal oedema is one of the manifestations associated with right‐sided heart failure (HF), which is known to be associated with poorer patient outcomes.
Yuki Ikeda, Shunsuke Ishii, Kenji Maemura, Takumi Oki, Mayu Yazaki, Teppei Fujita, Takeru Nabeta, Emi Maekawa, Toshimi Koitabashi, Junya Ako   +9 more
doaj   +2 more sources

Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives [PDF]

Journal of Patient Experience
Loop diuretics are strongly recommended in patients with chronic congestive heart failure (HF) to alleviate signs and symptoms of fluid overload. Loop diuretics help relieve congestive symptoms and reduce mortality, but may have side effects. This survey
Xin Pan PharmD, MPH, Christopher S Wilcox MD, PhD, Bertram Pitt MD, Salim Shah MPhil, PhD, Anandi V Law B.Pharm., MS, PhD, FAPhA   +4 more
doaj   +2 more sources

Clinical phenotypes according to diuretic combination in acute heart failure

Hellenic Journal of Cardiology, 2023
Background: The treatment of congestion in heart failure (HF) is a challenge despite the therapeutic arsenal available. The aim of this study was to analyze different combinations of diuretics used to resolve congestion in patients admitted for ...
Raquel López-Vilella, Pablo Jover Pastor, Víctor Donoso Trenado, Ignacio Sánchez-Lázaro, Luis Martínez Dolz, Luis Almenar Bonet   +5 more
doaj   +1 more source

Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study.

PLoS ONE, 2023
ObjectivesWe examined loop diuretic treatment before and 1-year after transcatheter aortic valve implantation (TAVI), as a proxy for changes in symptom severity and secondly assessed how changes in loop diuretics related to mortality risk ...
Xenia Begun, Jawad Haider Butt, Søren Lund Kristensen, Peter Ejvin Weeke, Ole De Backer, Morten Schou, Lars Køber, Emil Loldrup Fosbøl   +7 more
doaj   +1 more source

Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study

BMC Medicine, 2021
Background Patients with atrial fibrillation (AF) complicated by heart failure (HF) have a poor prognosis. We investigated whether long term loop-diuretic therapy in patients with AF and no known diagnosis of HF, as a potential surrogate marker of ...
Rosita Zakeri, Ann D. Morgan, Varun Sundaram, Chloe Bloom, John G. F. Cleland, Jennifer K. Quint   +5 more
doaj   +1 more source